We are live on ! Find out more
AQST icon

Aquestive Therapeutics
AQST

56 hedge funds and large institutions have $101M invested in Aquestive Therapeutics in 2019 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 7

134% more capital invested

Capital invested by funds: $43.2M → $101M (+$57.9M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

60% more funds holding

Funds holding: 35 → 56 (+21)

0.23% more ownership

Funds ownership: 54.25% → 54.47% (+0.23%)

0% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 12

Holders
56
Holders Change
+21
Holders Change %
+60%
% of All Funds
1.1%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
28
Increased
12
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$3.84M
2
WCM
Wildcat Capital Management
New York
+$2.37M
3
EP
Eversept Partners
New York
+$1.82M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.63M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.37M

Top Sellers

Rank Fund Capital Flow
1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$934K
2
BlackRock
BlackRock
New York
-$866K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$464K
4
BBA
Baker Bros. Advisors
New York
-$317K
5
WS
Wedbush Securities
California
-$188K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$281K +$198K +38,127 +373%
SIM
27
Spark Investment Management
New York
$275K +$247K +47,400 New
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$239K +$59.8K +11,485 +39%
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
$206K +$185K +35,475 New
OGC
30
One68 Global Capital
New York
$201K +$180K +34,543 New
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$200K +$179K +34,400 New
6CM
32
683 Capital Management
New York
$195K +$174K +33,422 New
TNA
33
True North Advisors
Texas
$187K +$168K +32,295 New
BBVA
34
Banco Bilbao Vizcaya Argentaria
Spain
$174K +$156K +30,000 New
CS
35
Credit Suisse
Switzerland
$167K +$149K +28,731 New
Bank of America
36
Bank of America
North Carolina
$153K +$137K +26,243 New
Jacobs Levy Equity Management
37
Jacobs Levy Equity Management
New Jersey
$146K -$464K -89,145 -78%
TI
38
Trexquant Investment
Connecticut
$130K +$116K +22,344 New
Morgan Stanley
39
Morgan Stanley
New York
$116K +$83.2K +15,987 +397%
Squarepoint
40
Squarepoint
New York
$109K -$115K -22,127 -54%
EGM
41
Engineers Gate Manager
New York
$107K +$95.7K +18,400 New
CSS
42
Cubist Systematic Strategies
Connecticut
$104K +$93.3K +17,926 New
OGC
43
Oak Grove Capital
New Hampshire
$87K +$78K +15,000 New
Northern Trust
44
Northern Trust
Illinois
$81K -$4.3K -826 -6%
TRCT
45
Tower Research Capital (TRC)
New York
$78K -$83.7K -16,086 -54%
Two Sigma Advisers
46
Two Sigma Advisers
New York
$64K +$57.2K +11,000 New
UBS Group
47
UBS Group
Switzerland
$58K – – –
Wells Fargo
48
Wells Fargo
California
$41K +$31.2K +6,000 +600%
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$22K -$96.6K -18,571 -83%
MAM
50
Meeder Asset Management
Ohio
$17K -$26.9K -5,161 -63%
1
2
3

AQST Hedge Fund Activity: Q4 2019 in Review

56 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Aquestive Therapeutics (AQST) for Q4 2019, worth a combined $101M — up 134% from $43.2M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AQST positions and 7 closed out — a net gain of 21 holders — while 12 added to existing stakes and 12 trimmed.

The largest buyer was Opaleye Management, opening a new position worth an estimated $3.84M. The largest seller was Massachusetts Financial Services, exiting entirely with an estimated $934K sold.

  • 56 institutional investors held Aquestive Therapeutics (AQST) as of Q4 2019, up from 35 in Q3 2019.
  • Funds reported $101M of Aquestive Therapeutics stock for Q4 2019, up 134% quarter-over-quarter.
  • 28 funds opened new Aquestive Therapeutics positions in Q4 2019 and 7 closed out, a net change of +21 holders.
  • The largest Aquestive Therapeutics buyer in Q4 2019 was Opaleye Management, an estimated $3.84M added.
  • The largest Aquestive Therapeutics seller in Q4 2019 was Massachusetts Financial Services, an estimated $934K sold.

Based on aggregated 13F filings for Q4 2019.